Physician profile
Brooks A Mirrer
NPI 1548229206
$1,001.30
in general payments reported to CMS, 2019-2025
11 companies · $25.76 in 2025
The $25.76 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $56.72 · 2021: $197 · 2022: $89.09 · 2023: $222 · 2024: $301 · 2025: $25.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $450 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $450.10 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $364.06 | 2019-2025 | Lifevest |
| Pfizer INC. | $158.53 | 2021-2024 | |
| Actelion Pharmaceuticals US, INC. | $128.09 | 2023 | Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals LP | $60.62 | 2021-2022 | |
| Irhythm Technologies, INC. | $59.24 | 2024 | Zio Monitor, Zio Xt Patch |
| Janssen Pharmaceuticals, INC | $58.77 | 2019-2021 | |
| Amgen INC. | $48.94 | 2021 | |
| Medtronic, INC. | $41.52 | 2023 | Azure Xt Dr Mri Surescan |
| Chiesi USA, INC. | $31.16 | 2019 | |
| Neurocrine Biosciences, INC. | $29.13 | 2022 | |
| Genentech USA, INC. | $21.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooks Mirrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.